Discover emerging treatments for people living with retinal diseases in a webinar hosted by the Carroll Center for the Blind and Ray Therapeutics. Participants will learn about Ray Therapeutics’ innovative approach and how its investigational therapies are designed to restore visual function, offering a potential new approach beyond treatments that primarily focus on slowing or managing disease progression.

Whether you’re living with a retinal condition, supporting a loved one, or simply interested in the latest advancements in vision research, this session offers a unique opportunity to learn directly from experts working to advance the future of vision restoration.

Event Details

Date: Thursday, November 19, 2026
Time: 1:00–2:15 P.M. ET
Location: Zoom (link provided upon registration)
Cost: Free

What to Expect

• Discover Ray Therapeutics’ innovative approach to developing treatments designed to restore visual function, rather than simply slowing disease progression.
• Explore the latest research and clinical development programs focused on Retinitis Pigmentosa, Stargardt disease, and Geographic Atrophy.
• Learn about optogenetics and emerging therapies being investigated as potential strategies for vision restoration.
• Gain a better understanding of clinical trials, including how they work, what researchers are learning, and the role they play in advancing new treatments.
• Participate in a Q&A with our speakers.

Speakers

We’re pleased to welcome two members of the Ray Therapeutics team who will share insights and answer your questions. Hear from:

• Alexandra S. Homann, OD FAAO – Medical Science Liaison
• Rachel Retajczyk – Executive Director of Patient Advocacy

If you have any questions or need help registering, please email development@car​roll.org or call (617) 969-6200 x 236.